Zobrazeno 1 - 10
of 275
pro vyhledávání: '"DEVIN E. ECKHOFF"'
Autor:
Takayuki Yamamoto, Qi Li, Hidetaka Hara, Liaoran Wang, Hongmin Zhou, Juan Li, Devin E. Eckhoff, A. Joseph Tector, Edwin C. Klein, Ray Lovingood, Mohamed Ezzelarab, David Ayares, Yi Wang, David K.C. Cooper, Hayato Iwase
Publikováno v:
Data in Brief, Vol 20, Iss , Pp 1965-1974 (2018)
This report is related to the research article entitled “B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy” (Yamamoto et al., in press). Herein we provide the data regarding pig artery patc
Externí odkaz:
https://doaj.org/article/9d0de587a0d34f36a487a19b6e26b0ae
Autor:
Saleh A. Alqahtani, Ahmet Gurakar, Hani Tamim, Thomas D. Schiano, Alan Bonder, Zachary Fricker, Marwan Kazimi, Devin E. Eckhoff, Michael P. Curry, Behnam Saberi
Publikováno v:
Journal of Clinical and Translational Hepatology. 10:814-824
Liver organ shortage remains a major health burden in the US, with more patients being waitlisted than the number of liver transplants (LTs) performed. This study investigated US national and regional trends in living donor LT (LDLT) and identified f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6617931e98d6a646d34d10fcfc8c009d
https://doi.org/10.14218/jcth.2021.00538
https://doi.org/10.14218/jcth.2021.00538
Autor:
Abhijit Jagdale, Hayato Iwase, David K. C. Cooper, Vineeta Kumar, Jayme E. Locke, Michael J. Hanaway, Douglas J. Anderson, Devin E. Eckhoff
Publikováno v:
Transplantation
There is a critical shortage of kidneys for transplantation into patients with kidney failure. Genetically-engineered pigs could provide an additional source. Increasing success is being reported of the transplantation of pig kidneys in nonhuman prim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce60997ca9a351f22c35fe37346b6be1
https://doi.org/10.1097/tp.0000000000003632
https://doi.org/10.1097/tp.0000000000003632
Autor:
Jeremy B, Foote, Mohamed H, Bikhet, Christophe, Hansen-Estruch, Mariyam, Javed, David, Ayares, Hidetaka, Hara, Abhinav, Humar, Devin E, Eckhoff, David K C, Cooper
Publikováno v:
Xenotransplantation. 29
We have seen hydronephrosis (obstructive nephropathy) at necropsy in 3 of 11 (21%) genetically-engineered pig kidneys that functioned in baboons for36 days, even when the clinical and histopathological features of rejection were minimal. We briefly r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caf49734ecd73efc57a3c3353f58bec2
https://doi.org/10.1111/xen.12779
https://doi.org/10.1111/xen.12779
Autor:
Jayme E. Locke, Douglas J. Anderson, Babak J. Orandi, David S. Goldberg, Devin E. Eckhoff, Robert M. Cannon
Publikováno v:
Transplantation. 105:1261-1272
BACKGROUND A safety net policy was implemented in August 2017 giving liver transplant alone (LTA) recipients with significant renal dysfunction posttransplant priority for subsequent kidney transplantation (KT). This study was undertaken to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::484b1d273cb0819f07aafa3f1ee80e8e
https://doi.org/10.1097/tp.0000000000003365
https://doi.org/10.1097/tp.0000000000003365
Autor:
James F. Markmann, Camille N. Kotton, Nahel Elias, Qing Yuan, Eve M. Roth, Omar J. Haque, Devin E. Eckhoff
Publikováno v:
Clinical Transplantation. 36
Transplantation of organs from increased risk donors for infection transmission (IRDs) is increasing. These organs confer survival benefit to recipients. This study examined transplant center acceptance policies for IRD kidneys across United Network
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7603d749a9e792edfc8f0e17548d64a3
https://doi.org/10.1111/ctr.14551
https://doi.org/10.1111/ctr.14551
Autor:
Devin E. Eckhoff, Asish C. Misra
Publikováno v:
Current opinion in organ transplantation. 26(5)
Purpose of review While liver transplantation is an established treatment for liver failure, the number of patients with liver failure amenable to such intervention far outnumbers the donor supply of livers. Technologies serving to bridge this gap ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abb51f84a0273d65ce563f9b3f7ff7f3
https://pubmed.ncbi.nlm.nih.gov/34325441
https://pubmed.ncbi.nlm.nih.gov/34325441
Autor:
Hongmin Zhou, Zhongqiang Zhang, A. Joseph Tector, Qi Li, Juan Li, Hayato Iwase, David Ayares, Hendrik Jan Schuurman, Takayuki Yamamoto, Jeremy B. Foote, Liaoran Wang, Devin E. Eckhoff, Edwin Klein, David K. C. Cooper, Hidetaka Hara, Ray Lovingood, Mohamed Ezzelarab
Publikováno v:
Transplantation. 103:2090-2104
The aims of this study were to evaluate the efficacy of US Food and Drug Administration-approved drugs in genetically engineered pig-to-baboon kidney xenotransplantation and compare the results with those using an anti-CD40 monoclonal antibody (mAb)-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1b211055be0c7e8811575c49079be85
https://doi.org/10.1097/tp.0000000000002796
https://doi.org/10.1097/tp.0000000000002796
Autor:
Darnell Mompoint-Williams, Jayme E. Locke, Michael J. Hanaway, Margaux N. Mustian, Rhiannon D. Reed, Babak J. Orandi, Paul A. MacLennan, Brittany A. Shelton, Douglas J. Anderson, Vineeta Kumar, Devin E. Eckhoff, Mark H. Deierhoi, Carlton J. Young, Katie Stegner
Publikováno v:
Ann Surg
OBJECTIVE In this study, we sought to assess likelihood of living donor kidney transplantation (LDKT) within a single-center kidney transplant waitlist, by race and sex, after implementation of an incompatible program. SUMMARY BACKGROUND DATA Dispari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cfafd4eb0943b47dd202e6cab3949cf
https://doi.org/10.1097/sla.0000000000003484
https://doi.org/10.1097/sla.0000000000003484
Autor:
Zheng-Yu Wang, James R. Butler, Devin E. Eckhoff, Joseph M. Ladowski, Clarkson Smith, Luz M. Reyes, Joseph Tector, Juliet L. Easlick, Jose Estrada, Gregory R. Martens, Matthew Tector, Richard A. Sidner
Publikováno v:
Transplantation. 103:1620-1629
Background Highly sensitized patients are difficult to match with suitable renal allograft donors and may benefit from xenotransplant trials. We evaluate antibody binding from sensitized patients to pig cells and engineered single allele cells to ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f285aab2744529c0c61df269ae4a6d5c
https://doi.org/10.1097/tp.0000000000002739
https://doi.org/10.1097/tp.0000000000002739